- Home
- APGE vs SHOO Comparison
APGE vs SHOO Comparison
Compare APGE & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- SHOO
- Stock Information
- Founded
- APGE 2022
- SHOO 1990
- Country
- APGE United States
- SHOO United States
- Employees
- APGE N/A
- SHOO N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- SHOO Shoe Manufacturing
- Sector
- APGE Health Care
- SHOO Consumer Discretionary
- Exchange
- APGE Nasdaq
- SHOO Nasdaq
- Market Cap
- APGE 2.4B
- SHOO 2.5B
- IPO Year
- APGE 2023
- SHOO 1993
- Fundamental
- Price
- APGE $55.35
- SHOO $34.90
- Analyst Decision
- APGE Strong Buy
- SHOO Buy
- Analyst Count
- APGE 8
- SHOO 8
- Target Price
- APGE $94.63
- SHOO $33.00
- AVG Volume (30 Days)
- APGE 923.1K
- SHOO 1.2M
- Earning Date
- APGE 11-12-2025
- SHOO 11-05-2025
- Dividend Yield
- APGE N/A
- SHOO 2.44%
- EPS Growth
- APGE N/A
- SHOO N/A
- EPS
- APGE N/A
- SHOO 1.28
- Revenue
- APGE N/A
- SHOO $2,319,527,000.00
- Revenue This Year
- APGE N/A
- SHOO $11.52
- Revenue Next Year
- APGE N/A
- SHOO $10.45
- P/E Ratio
- APGE N/A
- SHOO $26.98
- Revenue Growth
- APGE N/A
- SHOO 7.97
- 52 Week Low
- APGE $26.20
- SHOO $19.05
- 52 Week High
- APGE $63.50
- SHOO $46.99
- Technical
- Relative Strength Index (RSI)
- APGE 66.05
- SHOO 56.90
- Support Level
- APGE $54.80
- SHOO $34.01
- Resistance Level
- APGE $57.23
- SHOO $35.74
- Average True Range (ATR)
- APGE 2.61
- SHOO 1.20
- MACD
- APGE -0.18
- SHOO -0.20
- Stochastic Oscillator
- APGE 62.75
- SHOO 47.95
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About SHOO Steven Madden Ltd.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.